Cargando…

Pathologic complete response after neoadjuvant tislelizumab and chemotherapy for Pancoast tumor: A case report

A 60‐year‐old man was hospitalized because of numbness and weakness in the right upper limb. Magnetic resonance imaging revealed a large mass in the right upper lobe invading the right eighth cervical and first thoracic nerve root. Biopsy pathology confirmed primary lung adenocarcinoma with a clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Wen‐Fang, Xu, Wei, Huang, Wei‐Zhao, Lin, Gui‐Nan, Zeng, Yu‐Mei, Lin, Jie‐Shan, Wu, Min, Bao, Hua, Peng, Jie‐Wen, Jiang, Hai‐Ming, Wang, Heng‐Qiang, Wu, Ying‐Meng, Ye, Hong‐Yu, Liang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046127/ https://www.ncbi.nlm.nih.gov/pubmed/33656285 http://dx.doi.org/10.1111/1759-7714.13910

Ejemplares similares

Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real−world retrospective study
por: Wu, Wen-Jie, et al.
Publicado: (2023)

Pathological complete response to neoadjuvant tislelizumab plus chemotherapy in stage IIIB small cell lung cancer: A case report and literature review
por: Zhou, Nan, et al.
Publicado: (2023)

Pancoast Tumour
por: Raina, B. L.
Publicado: (1946)

Clinical outcomes of pancoast tumors treated with trimodality therapy
por: Lin, Tami Yu-Yu, et al.
Publicado: (2021)

Complete remission in a patient with metastatic gastric cancer receiving tislelizumab combined with chemotherapy: a case report
por: Zhu, Zhe, et al.
Publicado: (2023)

Charge of Prof. Pancoast
por: Pancoast,
Publicado: (1855)

Cloward’s approach for Pancoast neurogenic tumors: illustrative cases
por: Kuo, Yi-Hsuan, et al.
Publicado: (2021)

Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study
por: He, Wenwu, et al.
Publicado: (2022)

Dr. William H. Pancoast
Publicado: (1897)

Surgical Approaches to Pancoast Tumors
por: Petrella, Francesco, et al.
Publicado: (2023)

Postoperative pathological complete response in a patient with PD‑L1‑negative stage IIIB lung squamous cell carcinoma following neoadjuvant tislelizumab treatment combined with chemotherapy: A case report and literature review
por: Cui, Guanghua, et al.
Publicado: (2023)

Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Pairwise and Network Meta-Analysis of Pathological Complete Response
por: Weng, Zeng-Jie, et al.
Publicado: (2021)

Pancoast tumor approach through oesophagus
por: Tashi, Eritjan, et al.
Publicado: (2017)

Endoscopic ultrasound to the rescue of pancoast tumour
por: Giri, Suprabhat, et al.
Publicado: (2023)

Markers Associated With Tumor Recurrence in Patients With Breast Cancer Achieving a Pathologic Complete Response After Neoadjuvant Chemotherapy
por: Xie, Li-Yun, et al.
Publicado: (2022)

Discrepancy of Breast and Axillary Pathologic Complete Response and Outcomes in Different Subtypes of Node-positive Breast Cancer after Neoadjuvant Chemotherapy
por: Chen, Shin-Cheh, et al.
Publicado: (2021)

Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer
por: Hu, Shen-Bao, et al.
Publicado: (2019)

Pathological Complete Response Following Neoadjuvant Tislelizumab Monotherapy in Treatment-Naive Locally Advanced, MMR-Deficient/MSI-High Ascending Colon Cancer: A Case Report
por: Hei, Yue, et al.
Publicado: (2022)

Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer
por: Chen, Yong-He, et al.
Publicado: (2020)

Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy
por: Li, JunJie, et al.
Publicado: (2016)

Case Report: Life-threatening pancytopenia with tislelizumab followed by cerebral infarction in a patient with lung adenocarcinoma
por: Gu, Hang-Yu, et al.
Publicado: (2023)

Impact of age on pathological complete response and locoregional recurrence in locally advanced breast cancer after neoadjuvant chemotherapy
por: Chou, Hsu-Huan, et al.
Publicado: (2019)

Predicting pathological complete response after neoadjuvant chemotherapy: A nomogram combining clinical features and ultrasound semantics in patients with invasive breast cancer
por: Wang, Ke-Nie, et al.
Publicado: (2023)

Pancoast Tumor: The Role of Magnetic Resonance Imaging
por: Manenti, Guglielmo, et al.
Publicado: (2013)

Schwannoma: A Rare Etiology of Pancoast Syndrome
por: Alshammari, Fahad A, et al.
Publicado: (2021)

Pancoast Tumor With Cardiac Metastases and Intracardiac Thrombosis
por: Rao, Shiavax J., et al.
Publicado: (2023)

Deep learning-based predictive biomarker of pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer
por: Li, Fengling, et al.
Publicado: (2021)

Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer: A Phase 3 Randomized Clinical Trial
por: Wang, Jie, et al.
Publicado: (2021)

Development and validation of a radiopathomic model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer patients
por: Zhang, Jieqiu, et al.
Publicado: (2023)

Advances for achieving a pathological complete response for rectal cancer after neoadjuvant therapy
por: Cui, Jian, et al.
Publicado: (2016)

Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method
por: Qu, Yu‐Hong, et al.
Publicado: (2020)

Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer
por: Zeng, Wei-Gen, et al.
Publicado: (2015)

Treatment of stage III non-small cell lung cancer in the era of immunotherapy: pathological complete response to neoadjuvant pembrolizumab and chemotherapy
por: Yang, Zhang-Ru, et al.
Publicado: (2020)

Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy
por: Zhu, Jiujun, et al.
Publicado: (2020)

Tailoring neoadjuvant chemotherapy for patients with breast cancer who have achieved pathologic complete response
por: Li, Xianjun, et al.
Publicado: (2020)

Pancoast Tumor: The Overlooked Etiology of Shoulder Pain in Smokers
por: Shammari, Malak Al, et al.
Publicado: (2020)

Extraosseous Spread of Multiple Myeloma Mimicking Pancoast Tumor
por: Bansal, Kuldeep, et al.
Publicado: (2022)

Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma
por: Shueng, Pei-Wei, et al.
Publicado: (2011)

Radiomics of contrast-enhanced spectral mammography for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer
por: Zhang, Kun, et al.
Publicado: (2023)

Racial/Ethnic Differences and Trends in Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer
por: Ma, Sung Jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v8rn78vig8orm7dhvh8nr4utpk